A pilot study of adjuvant intraperitoneal 5-fluorouracil using 4% icodextrin as a novel carrier solution

European Journal of Surgical Oncology

Volumn 29, Issue 3, 2003, Pages 254-260

  Hosie, K B ^a   Kerr, D J ^b   Gilbert, Jenny A ^c   Downes, M ^b   Lakin, G ^a   Pemberton, G ^b   Timms, K ^a   Young, A ^b   Stanley, A ^b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c ML Laboratories PLC ^*  (United Kingdom)

Author keywords

5 fluorouracil; Adjuvant; Chemotherapy; Colorectal surgery; Home chemotherapy; Intraperitoneal chemotherapy infusions

Indexed keywords

DEXEMEL; DRUG CARRIER; FLUOROURACIL; ICODEXTRIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACTERIAL PERITONITIS; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; COLON RESECTION; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; DRUG SOLUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEASIBILITY STUDY; FEMALE; HAND FOOT SYNDROME; HOME CARE; HUMAN; INCIDENCE; LEUKOPENIA; LOW DRUG DOSE; MALE; MEDICAL DECISION MAKING; MICROBIOLOGY; MUCOSA INFLAMMATION; OSMOSIS; PERIOPERATIVE PERIOD; PERITONEAL CATHETER; PILOT STUDY; PRIORITY JOURNAL; RECTUM RESECTION; SELF MEDICATION; THROMBOCYTOPENIA;

EID: 0344211411     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejso.2002.1348     Document Type: Article

References (22)

1. Gunderson LL, Sosin H, Levitt S. Extrahepatic colon cancer, areas of failure in a reoperation series: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 1985; 11: 731-41.
2. Moertel CG, Flaming TR, Macdonald JS et al. Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: A final report. Ann Intern Med 1995; 122: 321-6.
3. Gray R, James R, Mossman J, Stenning S. AXIS - A suitable case for treatment. Br J Cancer 1991; 63: 8441-5.
4. Speyer JL, Sugarbaker PH, Collins JM, Dedrick RL, Klecker RW, Myers CE. Portal levels and hepatic clearance of 5-FU after I.P. administration in tumours. Cancer Res 1981; 41: 1916-22.
5. Goldberg JA, Kerr DJ, Willmott M, McKillop JH, McArdle CS. Pharmacokinetics and pharmacodynamics of locoregional 5-fluorouracil (5FU) in advanced colorectal liver metastases. Br J Cancer 1988; 57: 186-9.
6. Kerr DJ, Los G. Pharmacokinetic principles of locoregional chemotherapy. Cancer Surv 1993; 17: 105-22.
7. Erlanson M, Daniel-Szolgay E, Carlsson J. Relations between penetration, binding and average concentration of cytostatic drugs in human tumour spheroids. Cancer Chemother Pharmacol 1992; 29: 343-53.
8. Cunliffe WJ, Sugarbaker PH. Gastrointestinal malignancy: rationale for adjuvant therapy using early post-operative intraperitoneal chemotherapy (EPIC). Br J Surgery 1989; 76: 1082-90.
9. Piccart MJ, Speyer JL, Markman M, Ten Bokkel Huinink WW, Alberts D, Jenkins J, Muggia F. Intraperitoneal chemotherapy: technical experience at five institutions. Semin Oncol 1985; 12(3) (Suppl. 4): 90-6.
10. Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst 1997; 89: 480-7.
11. McArdle CS, Kerr DJ, O'Gorman P, Wotherspoon HA, Warren H, Watson D, Vinké BJ, Dobbie JW, El Eini DID. Pharmacokinetic study of 5-fluorouracil in a novel dialysate solution: a long-term intraperitoneal treatment approach for advanced colorectal carcinoma. Br J Cancer 1994; 70: 762-6.
12. Kerr DJ, Young AM, Neoptolemos JP, Sherman M, Van-Geene P, Stanley A, Ferry D, Dobbie JW, Vincke B, Gilbert J, El Eini D, Dombros N, Fountzilas G. Prolonged intraperitoneal infusion of 5-fluorouracil using a novel carrier solution. Br J Cancer 1996; 74: 2032-5.
13. Hosie KB, Gilbert JA, Kerr DJ, Brown CB, Peers EM. Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin. Drug Delivery 2001; 8: 9-12.
14. Anderson LW, et al. GC-MS method for the routine monitoring of 5-FU in patient plasma. J Chromatog Biomed Applications 1992; 581(2): 195-201.
15. Alberts DS, Liu PY, Hannigan EV, O'Toole R, Williams SD, Young JA, Franklin EW, Clarke-Pearson DL, Malviya VK, Dubeshter B, Adelson MD, Hoskins WJ. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 1996; 335: 1950-5.
16. Scheithauer W, Kornek GV, Marczell A, Karner J, Salem G, Greiner R, Burger D, Stöger F, Ritschel J, Kovats E, Vischer HM, Schneeweiss B, Depisch D. Combined intravenous and intraperitoneal chemotherapy with fluorouracil + leucovorin vs fluorouracil + levamisole for adjuvant therapy of resected colon carcinoma. Br J Cancer 1998: 77; 1349-54.
17. Joel SP, Gray J, Halstead F, Richards F, Gilbert J, Wilkinson V, Slevin ML, Seymour MT. The pharmacokinetics of single-dose intraperitoneal 5-fluouracil (5-FU) in saline and icodextrin. Br J Cancer 1999; 80(Suppl. 2): 94.
18. Harris BE, Song R, Soong SJ, Diasio RB. Relationships between dihydropyrimidine dehydrogenase activity and plasma 5-FU levels with evidence for circadian variation of enzymic activity and plasma drug levels in cancer patients receiving 5-FU by protracted continuous infusion. Cancer Res 1990; 50: 197-201.
19. Pestieau SR, Schnake KJ, Stuart OA, Sugarbaker PH. Impact of carrier solutions on pharmacokinetics of intraperitoneal chemotherapy. Cancer Chemother Pharmacol 2001; 47: 269-76.
20. Bruce J, Krukowski ZH, Al-Khairy G, Russell EM, Park KGM. Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery. Br J Surg 2001; 88: 1157-68.
21. Rodgers KE, Verco SJS, diZerega GS. Effects of intraperitoneal 4% icodextrin solution on the healing of bowel anastomoses and laparotomy incisions in rabbits. Colorec Dis 2002; in press
22. diZerega GS, Verco SJS, Young P, Kettel M, Kobak W, Martin D, Sanfilippo J, Peers EM, Scrimgeour A, Brown CB. A randomised, controlled pilot study of the safety and efficacy of 4% icodextrin solution (Adept®) in the reduction of adhesions following laparoscopic gynaecological surgery. Hum Reprod 2002; 17: 1030-7.